{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:38:11Z","timestamp":1790509091282,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15455-1","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:39:07Z","timestamp":1756402747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of HLA-B gene polymorphism and blood groups with COVID-19 susceptibility and severity"],"prefix":"10.1038","volume":"15","author":[{"given":"Muhammad Noaman","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Nughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiyaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffar","family":"Shojonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekzod","family":"Madaminov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdela Befa","family":"Kinki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"1","key":"15455_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12941-020-00384-w","volume":"19","author":"AA Rabaan","year":"2020","unstructured":"Rabaan, A. A. et al. SARS-CoV-2\/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic. Ann. Clin. Microbiol. Antimicrob. 19 (1), 40 (2020).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"15455_CR2","doi-asserted-by":"publisher","first-page":"111311","DOI":"10.1016\/j.chaos.2021.111311","volume":"152","author":"YS Malik","year":"2021","unstructured":"Malik, Y. S. et al. Responses to COVID-19 in South Asian association for regional Cooperation (SAARC) countries in 2020, a data analysis during a world of crises. Chaos Solitons Fractals. 152, 111311 (2021).","journal-title":"Chaos Solitons Fractals"},{"key":"15455_CR3","unstructured":"Rabaan, A. A. et al. Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols, (2022)."},{"key":"15455_CR4","first-page":"1","volume-title":"Computational Intelligence Techniques for combating COVID-","author":"S Guhathakurata","year":"2021","unstructured":"Guhathakurata, S., Saha, S., Kundu, S., Chakraborty, A. & Banerjee, J. S. South Asian countries are less fatal concerning COVID-19: a hybrid approach using machine learning and M-AHP. In Computational Intelligence Techniques for combating COVID- Vol. 19 1\u201326 (Springer, 2021)."},{"key":"15455_CR5","doi-asserted-by":"publisher","first-page":"551338","DOI":"10.3389\/fpubh.2020.00473","volume":"8","author":"JR Larsen","year":"2020","unstructured":"Larsen, J. R., Martin, M. R., Martin, J. D., Kuhn, P. & Hicks, J. B. Modeling the onset of symptoms of COVID-19. Front. Public. Health. 8, 551338 (2020).","journal-title":"Front. Public. Health"},{"key":"15455_CR6","doi-asserted-by":"crossref","unstructured":"Dieter, C. et al. Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 genes are associated with worse clinical outcomes in COVID-19. Genes\u00a014(1):29 (2022).","DOI":"10.3390\/genes14010029"},{"issue":"7","key":"15455_CR7","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1007\/s10238-023-01038-9","volume":"23","author":"V Pecoraro","year":"2023","unstructured":"Pecoraro, V., Cuccorese, M. & Trenti, T. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNF\u03b1 genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis. Clin. Experimental Med. 23 (7), 3251\u20133264 (2023).","journal-title":"Clin. Experimental Med."},{"key":"15455_CR8","doi-asserted-by":"publisher","first-page":"601886","DOI":"10.3389\/fimmu.2020.601886","volume":"11","author":"F Tavasolian","year":"2021","unstructured":"Tavasolian, F. et al. HLA, immune response, and susceptibility to COVID-19. Front. Immunol. 11, 601886 (2021).","journal-title":"Front. Immunol."},{"issue":"5","key":"15455_CR9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/tan.14047","volume":"96","author":"A Novelli","year":"2020","unstructured":"Novelli, A. et al. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. Hla 96(5), 610\u2013614 (2020).","journal-title":"Hla"},{"key":"15455_CR10","doi-asserted-by":"publisher","first-page":"605688","DOI":"10.3389\/fimmu.2020.605688","volume":"11","author":"R Littera","year":"2020","unstructured":"Littera, R. et al. Human leukocyte antigen complex and other Immunogenetic and clinical factors influence susceptibility or protection to SARS-CoV-2 infection and severity of the disease course. The Sardinian experience. Front. Immunol. 11, 605688 (2020).","journal-title":"Front. Immunol."},{"key":"15455_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02515-5","volume":"18","author":"S Pisanti","year":"2020","unstructured":"Pisanti, S. et al. Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19. J. Translational Med. 18, 1\u201316 (2020).","journal-title":"J. Translational Med."},{"key":"15455_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/jvi.00510-20","volume":"94","author":"A Nguyen","year":"2020","unstructured":"Nguyen, A. et al. Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J. Virol. 94, 13. https:\/\/doi.org\/10.1128\/jvi.00510-20 (2020).","journal-title":"J. Virol."},{"issue":"13","key":"15455_CR13","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1177\/2047487320922370","volume":"27","author":"X Dai","year":"2020","unstructured":"Dai, X. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. Eur. J. Prev. Cardiol. 27 (13), 1436\u20131437 (2020).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"20","key":"15455_CR14","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1182\/bloodadvances.2020002623","volume":"4","author":"RL Hoiland","year":"2020","unstructured":"Hoiland, R. L. et al. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv. 4 (20), 4981\u20134989 (2020).","journal-title":"Blood Adv."},{"issue":"1","key":"15455_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12889-022-12811-y","volume":"22","author":"HM Salman","year":"2022","unstructured":"Salman, H. M. et al. An epidemiological, strategic and response analysis of the COVID-19 pandemic in South asia: a population-based observational study. BMC Public. Health. 22 (1), 457 (2022).","journal-title":"BMC Public. Health"},{"issue":"12","key":"15455_CR16","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.7326\/M21-2780","volume":"174","author":"M Klompas","year":"2021","unstructured":"Klompas, M., Milton, D. K., Rhee, C., Baker, M. A. & Leekha, S. Current insights into respiratory virus transmission and potential implications for infection control programs: a narrative review. Ann. Intern. Med. 174 (12), 1710\u20131718 (2021).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"15455_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13073-022-01100-3","volume":"14","author":"CI van der Made","year":"2022","unstructured":"van der Made, C. I., Netea, M. G., van der Veerdonk, F. L. & Hoischen, A. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19. Genome Med. 14 (1), 96 (2022).","journal-title":"Genome Med."},{"issue":"2","key":"15455_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.medin.2020.08.004","volume":"45","author":"L Lorente","year":"2021","unstructured":"Lorente, L. et al. HLA genetic polymorphisms and prognosis of patients with COVID-19. Med. Intensiva. 45 (2), 96\u2013103 (2021).","journal-title":"Med. Intensiva"},{"issue":"1","key":"15455_CR19","first-page":"54","volume":"19","author":"E Mu\u00f1iz-Diaz","year":"2020","unstructured":"Mu\u00f1iz-Diaz, E. et al. Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients. Blood Transfus. 19 (1), 54 (2020).","journal-title":"Blood Transfus."},{"key":"15455_CR20","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s42399-020-00363-4","volume":"2","author":"A Sanyaolu","year":"2020","unstructured":"Sanyaolu, A. et al. Comorbidity and its impact on patients with COVID-19. SN Compr. Clin. Med. 2, 1069\u20131076 (2020).","journal-title":"SN Compr. Clin. Med."},{"issue":"6","key":"15455_CR21","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2022.01.029","volume":"185","author":"V Naranbhai","year":"2022","unstructured":"Naranbhai, V. et al. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell 185(6), 1041\u20131051 (2022).","journal-title":"Cell"},{"key":"15455_CR22","doi-asserted-by":"publisher","first-page":"565730","DOI":"10.3389\/fimmu.2020.565730","volume":"11","author":"MAM Pretti","year":"2020","unstructured":"Pretti, M. A. M. et al. Class I HLA allele predicted restricted antigenic coverages for Spike and nucleocapsid proteins are associated with deaths related to COVID-19. Front. Immunol. 11, 565730 (2020).","journal-title":"Front. Immunol."},{"issue":"7972","key":"15455_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41586-023-06331-x","volume":"620","author":"DG Augusto","year":"2023","unstructured":"Augusto, D. G. et al. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature 620 (7972), 128\u2013136 (2023).","journal-title":"Nature"},{"key":"15455_CR24","doi-asserted-by":"publisher","first-page":"100785","DOI":"10.1016\/j.blre.2020.100785","volume":"48","author":"N Liu","year":"2021","unstructured":"Liu, N. et al. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis. Blood Rev. 48, 100785 (2021).","journal-title":"Blood Rev."},{"issue":"5","key":"15455_CR25","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.3390\/ijms22052636","volume":"22","author":"F Pojero","year":"2021","unstructured":"Pojero, F. et al. The role of immunogenetics in COVID-19. Int. J. Mol. Sci. 22 (5), 2636 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"15455_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000512592","volume":"64","author":"M Biswas","year":"2021","unstructured":"Biswas, M., Rahaman, S., Biswas, T. K., Haque, Z. & Ibrahim, B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology 64(1), 36\u201347 (2021).","journal-title":"Intervirology"},{"issue":"1","key":"15455_CR27","doi-asserted-by":"publisher","first-page":"20848","DOI":"10.1038\/s41598-020-77632-8","volume":"10","author":"ME Dolan","year":"2020","unstructured":"Dolan, M. E. et al. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease. Sci. Rep. 10 (1), 20848 (2020).","journal-title":"Sci. Rep."},{"issue":"4","key":"15455_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/sji.12329","volume":"82","author":"YM Mosaad","year":"2015","unstructured":"Mosaad, Y. M. Clinical role of human leukocyte antigen in health and disease. Scand. J. Immunol. 82 (4), 283\u2013306 (2015).","journal-title":"Scand. J. Immunol."},{"issue":"8","key":"15455_CR29","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1007\/s10067-021-05636-4","volume":"40","author":"R Garcia-Silva","year":"2021","unstructured":"Garcia-Silva, R. et al. Mayan alleles of the HLA-DRB1 major histocompatibility complex might contribute to the genetic susceptibility to systemic lupus erythematosus in Mexican patients from Tapachula,\u00a0Chiapas. Clin. Rheumatol. 40(8), 3095\u20133103 (2021).","journal-title":"Clin. Rheumatol."},{"key":"15455_CR30","doi-asserted-by":"publisher","first-page":"039463202513217","DOI":"10.1177\/03946320251321747","volume":"39","author":"T Dhaouadi","year":"2025","unstructured":"Dhaouadi, T., Riahi, A., Ben Abdallah, T., Gorgi, Y. & Sfar, I. Association of HLA-DR, HLA-DQ, and HLA-B alleles with inclusion body myositis risk: A systematic review, a meta-analysis, a meta-regression and a trial sequential analysis. Int. J. ImmunoPathol Pharmacol. 39, 03946320251321747 (2025).","journal-title":"Int. J. ImmunoPathol Pharmacol."},{"issue":"4","key":"15455_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/cancers14040909","volume":"14","author":"AT Harding","year":"2022","unstructured":"Harding, A. T. & Heaton, N. S. The impact of estrogens and their receptors on immunity and inflammation during infection. Cancers 14(4), 909 (2022).","journal-title":"Cancers"},{"key":"15455_CR32","doi-asserted-by":"publisher","first-page":"777070","DOI":"10.3389\/fcimb.2021.777070","volume":"11","author":"Y Statsenko","year":"2022","unstructured":"Statsenko, Y. et al. Impact of age and sex on COVID-19 severity assessed from radiologic and clinical findings. Front. Cell. Infect. Microbiol. 11, 777070 (2022).","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15455-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T05:11:12Z","timestamp":1757481072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15455-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15455"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15455-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31775"}}